3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
6
Prostatic Neoplasms
4
Brain Neoplasms
4
Pancreatic Neoplasms
3
Glioblastoma
3
Sarcoma
2
Neoplasms
2
Lung Neoplasms
2
Gliosarcoma
2
Glioma
2
Urothelial Carcinoma of the Bladder
1
Thoracic Neoplasms
1
Stage IA-IIA Breast Cancer
1
Rhabdomyosarcoma
1
Retinoblastoma
1
Resected Pancreatic Adenocarcinoma
1
Recurrence
1
Pinealoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Meningioma
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Gastrointestinal Neoplasms
1
Eye Neoplasms
1
Esophageal Neoplasms
1
Ependymoma
1
Desmoplastic Small Round Cell Tumor
1
Chordoma
1
Chondrosarcoma
1
Interventions
Cisplatin
32
human papillomavirus vaccine, L1 type 16, 18
16
Brachytherapy
15
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
12
Paclitaxel
11
Bevacizumab
11
pembrolizumab
10
Platinum
9
1,2-diaminocyclohexaneplatinum II citrate
9
Topotecan
8
Radiotherapy, Intensity-Modulated
8
Radiation
8
Papillomavirus Vaccines
8
atezolizumab
6
Gemcitabine
6
Fluorodeoxyglucose F18
6
Cyclophosphamide
6
tisotumab vedotin
5
fludarabine phosphate
5
fludarabine
5
aldesleukin
5
Taxes
5
Radiotherapy
5
Magnetic Resonance Spectroscopy
5
Carboplatin
5
Vaccines, Synthetic
4
Nivolumab
4
Immunoglobulin G
4
Disulfides
4
Colposcopy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Uterine Cervical Neoplasms
×
Proton Therapy
×
Clear all
No trials found.